30/06/2015 04:24:57 Free Membership Login

   

Alexion Pharmaceuticals Inc

Visual Financials
Company Name: Alexion Pharmaceuticals Inc
Ticker Symbol: ALXN
CIK Number: 0000899866
WWW Address: http://www.alexionpharm.com
CEO: David Hallal
No. of Employees: 2,273
Common Issue Type: CS
Business Description:Alexion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 177.76 Unchanged 0.0 101.01 177.75  183.55 177.38 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 35,476.8 199.6 0.00 3.32 0.00 56.0 0.0 203.30 - 150.06
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close177.67$
PE Ratio - LTM56.0
Market Capitalisation35,476.8mil
Latest Shares Outstanding199.6mil
Earnings pS (EPS)3.32$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee982,725$
Effective Tax Rate0.2%
Float132.2mil
Float as % of Shares Outstanding0.7%
Foreign Sales1,504mil
Domestic Sales730mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin92.2%
EBITDA Margin41.3%
Pre-Tax Profit Margin39.0%
Assets Turnover59.4%
Return on Assets (ROA)17.5%
Return on Equity (ROE)23.1%
Return on Capital Invested (ROCI)22.0%
Current Ratio4.6
Leverage Ratio (Assets/Equity)1.3
Interest Cover293.5
Total Debt/Equity (Gearing Ratio)0.05
LT Debt/Total Capital3.0%
Working Capital pS10.97$
Cash pS0.00$
Book-Value pS17.62$
Tangible Book-Value pS12.33$
Cash Flow pS3.44$
Free Cash Flow pS2.57$
KEY FIGURES (LTM): Price info
Price/Book Ratio10.47
Price/Tangible Book Ratio0.00
Price/Cash Flow53.5
Price/Free Cash Flow71.9
P/E as % of Industry Group241.0%
P/E as % of Sector Segment48.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----2.012,221,5022,251,760
4 Weeks191.00157.13164.7811.9141,900,76939,916,166
13 Weeks191.00150.06180.242.341,902,316121,748,234
26 Weeks193.27150.06188.71-2.3-11,518,814194,408,294
52 Weeks203.30150.06156.2518.0131,311,016332,998,144
YTD193.27150.06--1.2-11,530,465191,308,177
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
184.73183.73171.03178.64178.730.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.420.70.42
Income0.170.90.55
Dividend0.0
Capital Spending0.41NA0.33
R&D28.58NA38.53
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %38.538.544.8
Earnings %81.081.045.4
EPS %78.378.340.7
EPS $0.180.180.37
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio52.10
Current Ratio4.6
Quick Ratio (Acid Test)3.9
Liquidity Ratio (Cash)4.79
Receivables Turnover5.2
Average Collection Period69
Working Capital/Equity66.3
Working Capital pS10.83
Cash-Flow pS3.17
Free Cash-Flow pS2.50
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio26.57
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio3.9
Total Debt/Equity (Gearing Ratio)0.05
LT Debt/Equity0.04
LT Debt/Capital Invested8.7
LT Debt/Total Liabilities5.8
Interest Cover293.5
Interest/Capital Invested0.08
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio8.76
Current P/E Ratio - LTM56.00
Enterprise Value (EV)/EBITDA37.75
Enterprise Value (EV)/Free Cash Flow71.79
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM10.47
Price/Cash Flow Ratio53.5
Price/Free Cash Flow Ratio - LTM71.9
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM72.3
P/E Ratio (26 weeks ago) - LTM83.4
P/E Ratio (52 weeks ago) - LTM93.3
5-Y High P/E Ratio69.6
5-Y Low P/E Ratio8.3
5-Y Average P/E Ratio66.9
Current P/E Ratio as % of 5-Y Average P/E62
P/E as % of Industry Group241.0
P/E as % of Sector Segment48.0
Current 12 Month Normalized P/E Ratio - LTM55.1
PER SHARE FIGURES
LT Debt pS0.06
Current Liabilities pS3.95
Tangible Book Value pS - LTM12.33
Book Value pS - LTM17.62
Capital Invested pS16.83
Cash pS - LTM0.00
Cash Flow pS - LTM3.44
Free Cash Flow pS - LTM2.57
Earnings pS (EPS)3.32
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin22.54
Free Cash Flow Margin 5YEAR AVG15.82
Net Profit Margin0.3
Net Profit Margin - 5YEAR AVRG.0.2
Equity Productivity0.68
Return on Equity (ROE)0.2
Return on Equity (ROE) - 5YEAR AVRG.0.2
Capital Invested Productivity0.66
Return on Capital Invested (ROCI)0.2
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.2
Assets Productivity0.60
Return on Assets (ROA)0.2
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin92.2
Gross Profit Margin - 5YEAR AVRG.0.9
EBITDA Margin - LTM41.3
EBIT Margin - LTM39.2
Pre-Tax Profit Margin0.3
Pre-Tax Profit Margin - 5YEAR AVRG.0.3
Effective Tax Rate10.5
Effective Tax Rate - 5YEAR AVRG.21.0
EFFICIENCY RATIOS
Cash Conversion Cycle6,199,558
Revenue per Employee982,725
Net Income per Employee289,007
Average Collection Period6,199,558
Receivables Turnover5.2
Day's Inventory Turnover Ratio
Inventory Turnover1.2
Inventory/Sales7.9
Accounts Payble/Sales1.97
Assets/Revenue1.67
Net Working Capital Turnover1.02
Fixed Assets Turnover1.59
Total Assets Turnover0.6
Revenue per $ Cash2.37
Revenue per $ Plant5.69
Revenue per $ Common Equity0.68
Revenue per $ Capital Invested0.66
Selling, General & Adm/tive (SG&A) as % of Revenue28.2
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue23.0
R&D Expense as % of Revenue - 5YEAR AVRG.23.0

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq alxn150630 04:24